Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents. 2010

Qing-Zhong Zheng, and Fei Zhang, and Kui Cheng, and Ying Yang, and Yu Chen, and Yong Qian, and Hong-Juan Zhang, and Huan-Qiu Li, and Chang-Fang Zhou, and Shu-Qing An, and Qing-Cai Jiao, and Hai-Liang Zhu
State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, People's Republic of China.

A series of amide-coupled benzoic nitrogen mustard derivatives as potential EGFR and HER-2 kinase inhibitors were synthesized and reported for the first time. Some of them exhibited significant EGFR and HER-2 inhibitory activity. Of all the studied compounds, compounds 5b and 5t exhibited the most potent inhibitory activity, which was comparable to the positive control erlotinib. Docking simulation was performed to position compounds 5b and 5t into the EGFR active site to determine the probable binding model. Antiproliferative assay results indicated that some of the benzoic nitrogen mustard derivatives possessed high antiproliferative activity against MCF-7. In particular, compounds 5b and 5t with potent inhibitory activity in tumor growth inhibition may function as potential antitumor agents.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009588 Nitrogen Mustard Compounds A group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen. They were formerly used as toxicants and vesicants, but now function as antineoplastic agents. These compounds are also powerful mutagens, teratogens, immunosuppressants, and carcinogens. Compounds, Nitrogen Mustard,Mustard Compounds, Nitrogen
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Qing-Zhong Zheng, and Fei Zhang, and Kui Cheng, and Ying Yang, and Yu Chen, and Yong Qian, and Hong-Juan Zhang, and Huan-Qiu Li, and Chang-Fang Zhou, and Shu-Qing An, and Qing-Cai Jiao, and Hai-Liang Zhu
October 2011, Bioorganic & medicinal chemistry letters,
Qing-Zhong Zheng, and Fei Zhang, and Kui Cheng, and Ying Yang, and Yu Chen, and Yong Qian, and Hong-Juan Zhang, and Huan-Qiu Li, and Chang-Fang Zhou, and Shu-Qing An, and Qing-Cai Jiao, and Hai-Liang Zhu
September 2010, European journal of medicinal chemistry,
Qing-Zhong Zheng, and Fei Zhang, and Kui Cheng, and Ying Yang, and Yu Chen, and Yong Qian, and Hong-Juan Zhang, and Huan-Qiu Li, and Chang-Fang Zhou, and Shu-Qing An, and Qing-Cai Jiao, and Hai-Liang Zhu
October 2019, Antibiotics (Basel, Switzerland),
Qing-Zhong Zheng, and Fei Zhang, and Kui Cheng, and Ying Yang, and Yu Chen, and Yong Qian, and Hong-Juan Zhang, and Huan-Qiu Li, and Chang-Fang Zhou, and Shu-Qing An, and Qing-Cai Jiao, and Hai-Liang Zhu
December 2007, Yao xue xue bao = Acta pharmaceutica Sinica,
Qing-Zhong Zheng, and Fei Zhang, and Kui Cheng, and Ying Yang, and Yu Chen, and Yong Qian, and Hong-Juan Zhang, and Huan-Qiu Li, and Chang-Fang Zhou, and Shu-Qing An, and Qing-Cai Jiao, and Hai-Liang Zhu
May 2012, Bioorganic & medicinal chemistry,
Qing-Zhong Zheng, and Fei Zhang, and Kui Cheng, and Ying Yang, and Yu Chen, and Yong Qian, and Hong-Juan Zhang, and Huan-Qiu Li, and Chang-Fang Zhou, and Shu-Qing An, and Qing-Cai Jiao, and Hai-Liang Zhu
May 2012, Bioorganic & medicinal chemistry,
Qing-Zhong Zheng, and Fei Zhang, and Kui Cheng, and Ying Yang, and Yu Chen, and Yong Qian, and Hong-Juan Zhang, and Huan-Qiu Li, and Chang-Fang Zhou, and Shu-Qing An, and Qing-Cai Jiao, and Hai-Liang Zhu
February 2012, Bioorganic & medicinal chemistry,
Qing-Zhong Zheng, and Fei Zhang, and Kui Cheng, and Ying Yang, and Yu Chen, and Yong Qian, and Hong-Juan Zhang, and Huan-Qiu Li, and Chang-Fang Zhou, and Shu-Qing An, and Qing-Cai Jiao, and Hai-Liang Zhu
January 2013, Chemical & pharmaceutical bulletin,
Qing-Zhong Zheng, and Fei Zhang, and Kui Cheng, and Ying Yang, and Yu Chen, and Yong Qian, and Hong-Juan Zhang, and Huan-Qiu Li, and Chang-Fang Zhou, and Shu-Qing An, and Qing-Cai Jiao, and Hai-Liang Zhu
October 2012, Bioorganic & medicinal chemistry letters,
Qing-Zhong Zheng, and Fei Zhang, and Kui Cheng, and Ying Yang, and Yu Chen, and Yong Qian, and Hong-Juan Zhang, and Huan-Qiu Li, and Chang-Fang Zhou, and Shu-Qing An, and Qing-Cai Jiao, and Hai-Liang Zhu
February 2012, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!